N-[(3S)-1-benzylpyrrolidin-3-yl]-(2-thienyl)benzamides:: Human dopamine D4 ligands with high affinity for the 5-HT2A receptor

被引:11
作者
Arora, J [1 ]
Bordeleau, M [1 ]
Dube, L [1 ]
Jarvie, K [1 ]
Mazzocco, L [1 ]
Peragine, J [1 ]
Tehim, A [1 ]
Egle, I [1 ]
机构
[1] NPS Pharmaceut, Mississauga, ON L4V 1V7, Canada
关键词
dopamine; serotonin; schizophrenia; D4; 5-HT2A;
D O I
10.1016/j.bmcl.2005.08.051
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of N-[(3S)-1-benzylpyrrolidin-3-y1]-(2-thienyl)benzamides 8 has been prepared and found to bind with high affinity to the human D-4 (hD(4)) and 5-HT2A receptors. Several compounds displayed selectivity for these receptors versus hD(2) and alpha(1), adrenergic receptors of over 500-fold. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5253 / 5256
页数:4
相关论文
共 20 条
[1]   Current Strategies for the Development of Novel Antipsychotic Drugs [J].
Bolos, Jordi .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2003, 3 (03) :239-251
[2]   Synthesis and preliminary pharmacological evaluation of 4′-arylalkyl analogues of clozapine.: II.: Effect of the nature and length of the linker [J].
Capuano, B ;
Crosby, IT ;
Lloyd, EJ ;
Podloucka, A ;
Taylor, DA .
AUSTRALIAN JOURNAL OF CHEMISTRY, 2003, 56 (09) :875-886
[3]   Synthesis and preliminary pharmacological evaluation of 4′-arylmethyl analogues of clozapine.: I.: The effect of aromatic substituents [J].
Capuano, B ;
Crosby, IT ;
Lloyd, EJ ;
Taylor, DA .
AUSTRALIAN JOURNAL OF CHEMISTRY, 2002, 55 (09) :565-576
[4]  
Chaki S, 2000, CNS DRUG REV, V6, P95
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]   N-(1-benzylpyrrolidin-3-yl)arylbenzamides as potent and selective human dopamine D4 antagonists [J].
Egle, I ;
Barriault, N ;
Bordeleau, M ;
Drage, J ;
Dube, L ;
Peragine, J ;
Mazzocco, L ;
Arora, J ;
Jarvie, K ;
Tehim, A .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (19) :4847-4850
[7]   JL 13, an atypical antipsychotic:: A preclinical review [J].
Ellenbroek, BA ;
Liégeois, JF .
CNS DRUG REVIEWS, 2003, 9 (01) :41-56
[8]   The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D-4 receptor [J].
Heuillet, E ;
Petitet, F ;
Mignani, S ;
Malleron, JL ;
Lavayre, J ;
Neliat, G ;
Doble, A ;
Blanchard, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 314 (1-2) :229-233
[9]   The dopamine D4 receptor:: a controversial therapeutic target [J].
Hrib, NJ .
DRUGS OF THE FUTURE, 2000, 25 (06) :587-611
[10]  
Kramer MS, 1997, ARCH GEN PSYCHIAT, V54, P567